Jin Medical International Ltd (ZJYL) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jin Medical International Ltd  (ZJYL)


Jin Medical International Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jin Medical International Ltd's ROI in the fourth quarter of 2025?
Jin Medical International Ltd achieved a return on average invested assets (ROI) of 4.75 % in its fourth quarter of 2025, which is below Jin Medical International Ltd's average return on investment, which stands at 8.32%.

ROI fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

Within the Healthcare sector 162 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 1381.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Investment Change TTM 13.42 % 17.74 % 17.17 % 22.61 % 63.44 %
Y / Y Net Income Change TTM -52.01 % - - - -
Investment (TTM) in Millions 30 30 30 28 29
Return On Investment (TTM) 4.75 % 9.98 % 10.29 % 10.83 % 11.22 %
ZJYL's Overall Ranking # 1381 # # # #
Seq. Investment Change TTM 0.83 % 3.13 % 5.2 % 3.68 % 4.67 %
Seq. Net Income Change TTM -52.01 % 0 % 0 % 0 % -
Net Income (TTM) in Millions 1 3 3 3 3

ZJYL Company Profile >> Back to ZJYL Roi Comparisons >> See Annual ZJYL Return On Investment



Return On Investment ZJYL's Ranking
Within: No.
Industry # 47
Sector # 163
Overall # 1381

Return On Investment Statistics
High Average Low
11.98 %
8.32 %
4.67 %
(Sep 30 2024)   (Sep 30 2025)







Financial Statements
Jin Medical International Ltd's IV. Quarter Investments $ 30 Millions ZJYL's Balance sheet
Jin Medical International Ltd's IV. Quarter Income $ 1 Millions Quarterly ZJYL's Income Statement
ZJYL's Income by Division See ZJYL's Income by Division


ZJYL Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023

Total Investments in Millions 30 29 24 0 0
Y / Y Investment Growth 3.57 % 19.07 % - - -
Net Income in Millions 1 3 3 0 0
Y / Y Net Income Growth -59.61 % 18.82 % - - -
Annual Return On Investment 4.67 % 11.98 % 12 % - -


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 4.67 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZJYL's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZJYL's Competitors
Subscribers only: Roi for Jin Medical International Ltd's Suppliers
Subscribers only: Return On Investment for ZJYL's Customers

Other Ratios
ZJYL's Roa ZJYL's Inventory Turnover Ratio ZJYL's Growth Rates ZJYL's Dividend Statistics
ZJYL's Profitability Ratios ZJYL's Asset Turnover Ratio ZJYL's Dividend Growth
ZJYL's Roe ZJYL's Valuation Ratios ZJYL's Financial Strength Ratios ZJYL's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI
Neurocrine Biosciences Inc   12.83 %
Msa Safety Inc  12.61 %
Semler Scientific inc   12.50 %
Stoke Therapeutics Inc   12.13 %
Alpha Pro Tech Ltd   12.02 %
Hims and Hers Health Inc   11.90 %
Ufp Technologies Inc   11.85 %
Innoviva Inc   11.82 %
Pacific Health Care Organization Inc  11.79 %
Solventum Corporation  11.75 %
Universal Health Services Inc   11.70 %
Encompass Health Corporation  11.65 %
Edwards Lifesciences Corporation  11.56 %
3m Company  11.54 %
Transmedics Group Inc   11.38 %
Champions Oncology Inc   11.14 %
Progyny Inc   11.00 %
Amgen Inc   10.70 %
Penumbra Inc  9.89 %
Utah Medical Products Inc  9.80 %
Lemaitre Vascular Inc   9.65 %
Protalix Biotherapeutics inc   9.52 %
Insulet Corporation  9.47 %
Cryoport inc   9.46 %
Globus Medical Inc   9.41 %
Keros Therapeutics Inc   9.28 %
Haemonetics Corporation  9.20 %
Lantheus Holdings Inc   9.10 %
Viemed Healthcare Inc   9.08 %
Ge Healthcare Technologies Inc   9.03 %

Date modified: 2026-07-07T14:09:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.